Results 211 to 220 of about 63,270 (301)

The immune response to live, attenuated peste des petits ruminants virus vaccines.

, 2019
Sophia Hodgson
openalex   +1 more source

A Canarypox Vector Expressing Cytomegalovirus (CMV) Glycoprotein B Primes for Antibody Responses to a Live Attenuated CMV Vaccine (Towne) [PDF]

, 1999
Stuart P. Adler, Stanley A. Plotkin, Éva Gönczöl, M. Cadoz, Claude Méric, Jian Ben Wang, P. Dellamonica, Al M. Best, John M. Zahradnik, S Pincus, Klára Berencsi, William I. Cox, Zsófia Gyulai   +12 more
openalex   +1 more source

Live attenuated polio vaccine

South African Medical Journal, 2018
No Abstract.
openaire   +1 more source

Efficacy and Tolerability of Weekly Bortezomib, Lenalidomide, and Dexamethasone Protocols in Transplant‐Ineligible Newly Diagnosed Myeloma: An Australian Real‐World, Multicenter Study

Asia-Pacific Journal of Clinical Oncology, EarlyView.
RVD with weekly bortezomib dosing in real‐world newly diagnosed transplant‐ineligible myeloma shows comparable efficacy and reduced toxicity compared to twice‐weekly trial protocols. ABSTRACT Background Lenalidomide, bortezomib, and dexamethasone (RVD) remains a standard of care regimen for newly diagnosed multiple myeloma in centers without access to ...
Samantha Kurniawan, Angela Hwang, Nicole Wong Doo, Tracy King, Christian Bryant, Jennifer Zhang, Kristina Whelan, Parisa Fani‐Molky, Giselle Kidson‐Gerber, Annmarie Bosco, Nada Hamad, Gurdeep Parmar, Fiona Kwok, Sam Lai, Silvia Ling, P. Joy Ho, Georgia McCaughan, Adam Bryant   +17 more
wiley   +1 more source

Update on Non‐Biological and RNA‐Based Therapeutics in Chronic Inflammatory Diseases: Precision Medicine Through Small Molecules: An EAACI Position Paper

Allergy, EarlyView.
ABSTRACT In the last decades, critical advancements in research technology and knowledge on disease mechanisms steered therapeutic approaches for chronic inflammatory diseases towards unprecedented target specificity. For allergic and chronic lung diseases, biologic drugs pioneered this goal, acquiring on the way—through the clinical use of monoclonal ...
F. Roth‐Walter, I. M. Adcock, C. Benito‐Villalvilla, R. Bianchini, L. Bjermer, G. Caramori, L. Cari, K. F. Chung, Z. Diamant, I. Eguiluz‐Gracia, E. F. Knol, M. Jesenak, F. Levi‐Schaffer, G. Nocentini, L. O'Mahony, O. Palomares, F. Redegeld, M. Sokolowska, B. Van Esch, M. Zurlo, C. Stellato   +20 more
wiley   +1 more source

Comparison of Safety and Efficacy between Intradermal and Intramuscular Administration of a Variable-Dose NADC30-like Porcine Reproductive and Respiratory Syndrome Live Attenuated Vaccine (Strain SD-R)

Hongliang Zhang, Jiahao Shi, Xueli Zhang, Gaijie Wang, Ziyu Song, Chao Li, Bangjun Gong, Zhenyang Guo, Jinhao Li, Zixuan Feng, Haonan Kang, Tianze Chen, Ailin Dong, Shaochong Yang, Yan-Dong Tang, Lirun Xiang, Kuan Zhao, Ziyu Zhou, Qian Wang, Jinmei Peng, Guohui Zhou, Tongqing An, Xuehui Cai, Zhi-Jun Tian, Hu Xu   +24 more
openalex   +1 more source

Comparison of Immunogenicity and Protective Efficacy of PPR Live Attenuated Vaccines (Nigeria 75/1 and Sungri 96) Administered by Intranasal and Subcutaneous Routes. [PDF]

Vaccines (Basel), 2020
Mahapatra M, Selvaraj M, Parida S.
europepmc   +1 more source

T Cell Microenvironmental Impacts and Therapeutic Opportunities: Application to Human Testicular Germ Cell Tumors

Andrology, EarlyView.
ABSTRACT Testicular germ cell tumors (TGCT) are the leading malignancy in adolescent and young adult males, yet the immunological and cellular mechanisms governing their tumor microenvironment (TME) remain poorly understood. Here, we present a comprehensive review of TGCT pathobiology with a focus on the immune landscape, particularly the role of tumor‐
R Islam, M Figura, J Heyer, S Lieber, M Huber, KL Loveland, HC Schuppe, Daniela Fietz   +7 more
wiley   +1 more source

Pathogenic Conversion of Live Attenuated Simian Immunodeficiency Virus Vaccines Is Associated with Expression of Truncated Nef

, 2000
Earl T. Sawai, Malak Hamza, Michael Ye, Karen E.S. Shaw, Paul A. Luciw   +4 more
openalex   +1 more source

A Spotlight on Yolk‐sac Tumors: Molecular Pathology, Current Diagnostics, and Novel Therapeutics

Andrology, EarlyView.
ABSTRACT Background Yolk‐sac tumors are an aggressive subtype of testicular cancer that significantly contribute to disease progression and therapy resistance, especially in adults. While testicular cancer generally has high cure rates with cisplatin‐based treatment, adult yolk‐sac tumors often appear as components of mixed tumors with poor response to
Evangelos Prokakis, Lisa Schneider, Felix Bremmer, Daniel Nettersheim   +3 more
wiley   +1 more source